201 related articles for article (PubMed ID: 30359667)
1. The impact of digestion is essential to the understanding of milk as a drug delivery system for poorly water soluble drugs.
Boyd BJ; Salim M; Clulow AJ; Ramirez G; Pham AC; Hawley A
J Control Release; 2018 Dec; 292():13-17. PubMed ID: 30359667
[TBL] [Abstract][Full Text] [Related]
2. Low-Frequency Raman Scattering Spectroscopy as an Accessible Approach to Understand Drug Solubilization in Milk-Based Formulations during Digestion.
Salim M; Fraser-Miller SJ; Be Rziņš KR; Sutton JJ; Ramirez G; Clulow AJ; Hawley A; Beilles S; Gordon KC; Boyd BJ
Mol Pharm; 2020 Mar; 17(3):885-899. PubMed ID: 32011151
[TBL] [Abstract][Full Text] [Related]
3. Solubilisation behaviour of poorly water-soluble drugs during digestion of solid SMEDDS.
Vithani K; Hawley A; Jannin V; Pouton C; Boyd BJ
Eur J Pharm Biopharm; 2018 Sep; 130():236-246. PubMed ID: 29981444
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS).
Thomas N; Holm R; Müllertz A; Rades T
J Control Release; 2012 May; 160(1):25-32. PubMed ID: 22405903
[TBL] [Abstract][Full Text] [Related]
5. Interactions of Artefenomel (OZ439) with Milk during Digestion: Insights into Digestion-Driven Solubilization and Polymorphic Transformations.
Salim M; Khan J; Ramirez G; Clulow AJ; Hawley A; Ramachandruni H; Boyd BJ
Mol Pharm; 2018 Aug; 15(8):3535-3544. PubMed ID: 29932660
[TBL] [Abstract][Full Text] [Related]
6. Impact of Ferroquine on the Solubilization of Artefenomel (OZ439) during in Vitro Lipolysis in Milk and Implications for Oral Combination Therapy for Malaria.
Salim M; Khan J; Ramirez G; Murshed M; Clulow AJ; Hawley A; Ramachandruni H; Beilles S; Boyd BJ
Mol Pharm; 2019 Apr; 16(4):1658-1668. PubMed ID: 30830789
[TBL] [Abstract][Full Text] [Related]
7. Revisiting dispersible milk-drug tablets as a solid lipid formulation in the context of digestion.
Binte Abu Bakar SY; Salim M; Clulow AJ; Hawley A; Boyd BJ
Int J Pharm; 2019 Jan; 554():179-189. PubMed ID: 30391337
[TBL] [Abstract][Full Text] [Related]
8. Addition of Cationic Surfactants to Lipid-Based Formulations of Poorly Water-Soluble Acidic Drugs Alters the Phase Distribution and the Solid-State Form of the Precipitate Upon In Vitro Lipolysis.
Khan J; Rades T; Boyd BJ
J Pharm Sci; 2018 Sep; 107(9):2420-2427. PubMed ID: 29859958
[TBL] [Abstract][Full Text] [Related]
9. Small-volume
Khan NF; Salim M; Binte Abu Bakar SY; Ristroph K; Prud'homme RK; Hawley A; Boyd BJ; Clulow AJ
Int J Pharm X; 2022 Dec; 4():100113. PubMed ID: 35243327
[TBL] [Abstract][Full Text] [Related]
10. Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids.
Kaukonen AM; Boyd BJ; Charman WN; Porter CJ
Pharm Res; 2004 Feb; 21(2):254-60. PubMed ID: 15032306
[TBL] [Abstract][Full Text] [Related]
11. In Situ Lipolysis and Synchrotron Small-Angle X-ray Scattering for the Direct Determination of the Precipitation and Solid-State Form of a Poorly Water-Soluble Drug During Digestion of a Lipid-Based Formulation.
Khan J; Hawley A; Rades T; Boyd BJ
J Pharm Sci; 2016 Sep; 105(9):2631-2639. PubMed ID: 26359590
[TBL] [Abstract][Full Text] [Related]
12. The Precipitation Behavior of Poorly Water-Soluble Drugs with an Emphasis on the Digestion of Lipid Based Formulations.
Khan J; Rades T; Boyd B
Pharm Res; 2016 Mar; 33(3):548-62. PubMed ID: 26597939
[TBL] [Abstract][Full Text] [Related]
13. How relevant are assembled equilibrium samples in understanding structure formation during lipid digestion?
Phan S; Salentinig S; Hawley A; Boyd BJ
Eur J Pharm Biopharm; 2015 Oct; 96():117-24. PubMed ID: 26212786
[TBL] [Abstract][Full Text] [Related]
14. Lipid-Based Formulations Can Enable the Model Poorly Water-Soluble Weakly Basic Drug Cinnarizine To Precipitate in an Amorphous-Salt Form During In Vitro Digestion.
Khan J; Rades T; Boyd BJ
Mol Pharm; 2016 Nov; 13(11):3783-3793. PubMed ID: 27631273
[TBL] [Abstract][Full Text] [Related]
15. Ionic Liquid Forms of Weakly Acidic Drugs in Oral Lipid Formulations: Preparation, Characterization, in Vitro Digestion, and in Vivo Absorption Studies.
Sahbaz Y; Nguyen TH; Ford L; McEvoy CL; Williams HD; Scammells PJ; Porter CJH
Mol Pharm; 2017 Nov; 14(11):3669-3683. PubMed ID: 28954512
[TBL] [Abstract][Full Text] [Related]
16. Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623.
McEvoy CL; Trevaskis NL; Feeney OM; Edwards GA; Perlman ME; Ambler CM; Porter CJH
Mol Pharm; 2017 Dec; 14(12):4525-4538. PubMed ID: 29076741
[TBL] [Abstract][Full Text] [Related]
17. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.
Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
J Pharm Pharmacol; 2010 Jul; 62(7):856-65. PubMed ID: 20636873
[TBL] [Abstract][Full Text] [Related]
18. Colloidal aspects of dispersion and digestion of self-dispersing lipid-based formulations for poorly water-soluble drugs.
Vithani K; Jannin V; Pouton CW; Boyd BJ
Adv Drug Deliv Rev; 2019 Mar; 142():16-34. PubMed ID: 30677448
[TBL] [Abstract][Full Text] [Related]
19. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
20. Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium.
Borkar N; Xia D; Holm R; Gan Y; Müllertz A; Yang M; Mu H
Eur J Pharm Sci; 2014 Jan; 51():204-10. PubMed ID: 24134899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
